IFP Advisors’s Chembio diagnostics, Inc. CEMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-375
| Closed | -$170 | – | 3626 |
|
|
2023
Q2 | $170 | Hold |
375
| – | – | ﹤0.01% | 3328 |
|
|
2023
Q1 | $3.86K | Hold |
375
| – | – | ﹤0.01% | 2673 |
|
|
2022
Q4 | $4K | Hold |
375
| – | – | ﹤0.01% | 3967 |
|
|
2022
Q3 | $4K | Hold |
375
| – | – | ﹤0.01% | 4183 |
|
|
2022
Q2 | $4K | Hold |
375
| – | – | ﹤0.01% | 3946 |
|
|
2022
Q1 | $4K | Hold |
375
| – | – | ﹤0.01% | 3945 |
|
|
2021
Q4 | $1K | Hold |
375
| – | – | ﹤0.01% | 3214 |
|
|
2021
Q3 | $1K | Hold |
375
| – | – | ﹤0.01% | 3237 |
|
|
2021
Q2 | $1K | Hold |
375
| – | – | ﹤0.01% | 3000 |
|
|
2021
Q1 | $1K | Hold |
375
| – | – | ﹤0.01% | 2936 |
|
|
2020
Q4 | $2K | Hold |
375
| – | – | ﹤0.01% | 2690 |
|
|
2020
Q3 | $2K | Hold |
375
| – | – | ﹤0.01% | 2560 |
|
|
2020
Q2 | $1K | Sell |
375
-250
| -40% | -$2.37K | ﹤0.01% | 2687 |
|
|
2020
Q1 | $3K | Hold |
625
| – | – | ﹤0.01% | 2306 |
|
|
2019
Q4 | $3K | Hold |
625
| – | – | ﹤0.01% | 2443 |
|
|
2019
Q3 | $4K | Buy |
+625
| New | +$3.73K | ﹤0.01% | 2481 |
|
|
2019
Q1 | – | Sell |
-375
| Closed | -$2K | – | 3973 |
|
|
2018
Q4 | $2K | Buy |
+375
| New | +$2.76K | ﹤0.01% | 3251 |
|
|
2017
Q4 | – | Sell |
-625
| Closed | -$4K | – | 4408 |
|
|
2017
Q3 | $4K | Hold |
625
| – | – | ﹤0.01% | 3577 |
|
|
2017
Q2 | $4K | Hold |
625
| – | – | ﹤0.01% | 3578 |
|
|
2017
Q1 | $3K | Buy |
625
+375
| +150% | +$2.18K | ﹤0.01% | 3611 |
|
|
2016
Q4 | $2K | Buy |
+250
| New | +$1.73K | ﹤0.01% | 3728 |
|
IFP Advisors's CEMI Position: Q3 2023 in Review
IFP Advisors sold out of Chembio diagnostics, Inc. (CEMI) in Q3 2023, closing a stake of 375 shares — an estimated $170 sold.
IFP Advisors first reported a position in CEMI in Q4 2016 and held it in 21 quarters. The position peaked at $4K in Q4 2022. 0 funds tracked by Wall St. Rank hold CEMI as of Q3 2023.
- IFP Advisors reported no remaining Chembio diagnostics, Inc. position as of Q3 2023 after selling out during the quarter.
- IFP Advisors sold 375 Chembio diagnostics, Inc. shares in Q3 2023, an estimated $170.
- IFP Advisors first reported a position in Chembio diagnostics, Inc. in Q4 2016 and held it in 21 quarters.
- IFP Advisors's Chembio diagnostics, Inc. position peaked at $4K in Q4 2022.
- 0 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q3 2023.
Based on IFP Advisors's 13F filing for Q3 2023, filed 12 Oct 2023.